Your browser doesn't support javascript.
loading
Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.
Rayson, Daniel; Gandhi, Sonal; Joy, Anil A; Brezden-Masley, Christine; Gelmon, Karen A; Sehdev, Sandeep; Cescon, David; Chia, Stephen.
Afiliação
  • Rayson D; Division of Medical Oncology, Department of Medicine, Queen Elizabeth II Health Sciences Center, Halifax, NS B3H 2Y9, Canada.
  • Gandhi S; Division of Medical Oncology/Hematology, Odette Cancer Centre Sunnybrook Health Sciences Centre, Toronto, ON M5M 3J1, Canada.
  • Joy AA; Division of Medical Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
  • Brezden-Masley C; Division of Medical Oncology, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
  • Gelmon KA; Division of Medical Oncology, British Columbia Cancer Centre, Vancouver, BC V5Z 4E6, Canada.
  • Sehdev S; Department of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Cescon D; Department of Medical Oncology, University Health Network, Toronto, ON M5G 1Z5, Canada.
  • Chia S; Division of Medical Oncology, British Columbia Cancer Centre, Vancouver, BC V5Z 4E6, Canada.
Curr Oncol ; 29(12): 9891-9895, 2022 12 16.
Article em En | MEDLINE | ID: mdl-36547192
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article